AC Immune reports positive week-100 data for Parkinson's vaccine trial

September 23, 2026 7:00 AM

AC Immune SA (NASDAQ: ACIU) announced positive safety and immunogenicity results through week-100 in Part 1 of VacSYn, a randomized ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found